Intrinsic impacts of the expression of PD-L1 on postoperative recurrence in EGFR-mutated lung adenocarcinoma
PD-L1 positivity emerged as an independent risk factor for RFS in patients with <i>EGFR</i>-mutant resected lung adenocarcinoma. These findings may provide valuable insights into the prognostic impact of PD-L1 expression and guide the implementation of postoperative adjuvant therapy in this patient population.
Authors
- Atsushi Ito
- Yūta Suzuki (ORCID: https://orcid.org/0000-0003-4272-2776)
- Tadashi Sakaguchi (ORCID: https://orcid.org/0000-0003-1103-4276)
- Osamu Hataji (ORCID: https://orcid.org/0000-0002-1946-2585)
- Hiroki Yasui
- Yoichi Nishii (ORCID: https://orcid.org/0000-0003-4193-2077)
- Kentaro Ito (ORCID: https://orcid.org/0000-0001-5461-9894)
- Motoshi Takao (ORCID: https://orcid.org/0000-0003-1305-8554)
- S. Kano
- Tomohito Tarukawa
- Osamu Taguchi
Institutions
- Mie University (JP)
- Soka Municipal Hospital (JP)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-08-30
- DOI
- https://doi.org/10.3389/fonc.2024.1415729
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00